Actinium Pharmaceuticals Net Tangible Assets

Actinium Pharmaceuticals (ATNM) currently reports a net tangible assets of $30M as of June 2026. That compares with $19M in the prior-year period — up 59.4% year over year. Use the charts on this page to explore Actinium Pharmaceuticals's net tangible assets history and peer comparisons.

Actinium Pharmaceuticals's net tangible assets increased from $19M to $30M — a 59.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Actinium Pharmaceuticals reported $30M in net tangible assets as of June 2026. That compares with $19M in the prior-year period — up 59.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $30M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Actinium Pharmaceuticals, and consider following ATNM for alerts when major investors trade the stock.

Actinium Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $30M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATNM with unrelated industries.